Wen-Feng Fang
Overview
Explore the profile of Wen-Feng Fang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1601
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Li A, Ling L, Qin H, Arabi Y, Myatra S, Egi M, et al.
Crit Care
. 2024 Jan;
28(1):30.
PMID: 38263076
Background: There is conflicting evidence on association between quick sequential organ failure assessment (qSOFA) and sepsis mortality in ICU patients. The primary aim of this study was to determine the...
12.
Phua J, Kulkarni A, Mizota T, Hashemian S, Lee W, Permpikul C, et al.
Lancet Reg Health West Pac
. 2023 Dec;
44:100982.
PMID: 38143717
Background: The coronavirus disease 2019 (COVID-19) pandemic highlighted the importance of critical care. The aim of the current study was to compare the number of adult critical care beds in...
13.
Tsai Y, Hung K, Fang W
Nutrients
. 2023 Sep;
15(18).
PMID: 37764757
Sepsis remains a critical concern in healthcare, and its management is complicated when patients have pre-existing diabetes and varying body mass indexes (BMIs). This retrospective multicenter observational study, encompassing data...
14.
Chang H, Wang C, Tseng C, Huang K, Chen Y, Chang Y, et al.
Thorac Cancer
. 2023 Sep;
14(32):3208-3216.
PMID: 37737541
Background: Despite the well-established efficacies of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), there is limited real-world evidence comparing their effectiveness according...
15.
Hung K, Chen T, Lee Y, Fang W
Nutrients
. 2023 Sep;
15(17).
PMID: 37686846
The study aimed to determine whether using body composition data acquired through bio-electrical impedance analysis (BIA) to adjust diet formulas could improve outcomes in septic patients. There were 132 septic...
16.
Lin K, Fang W, Sung P, Huang K, Chiang J, Chen Y, et al.
Cell Transplant
. 2023 Aug;
32:9636897231190178.
PMID: 37592717
This study tested whether human umbilical cord-derived mesenchymal stem cells (HUCDMSCs) treatment effectively protected the rat lung against acute respiratory distress syndrome (ARDS) injury, and benefits of early and dose-dependent...
17.
Lai C, Chen W, Kuo L, Wang Y, Fu P, Ku S, et al.
Medicine (Baltimore)
. 2023 Jul;
102(28):e34284.
PMID: 37443505
The objective was to compare the clinical efficacy of cefoperazone-sulbactam with piperacillin-tazobactam in the treatment of severe community-acquired pneumonia (SCAP). The retrospective study was conducted from March 1, 2018 to...
18.
Han S, Wang G, Yang Y, Fang W, Sun B, Zhang J, et al.
Signal Transduct Target Ther
. 2023 May;
8(1):191.
PMID: 37246200
No abstract available.
19.
Tang L, Li X, Li Z, Liu Z, Lin M, Zhou H, et al.
BMC Med
. 2023 Mar;
21(1):94.
PMID: 36927541
Background: Previous studies have shown that monotherapy with apatinib, an oral tyrosine kinase inhibitor, has promising efficacy for treating recurrent or metastatic (RM) nasopharyngeal carcinoma (NPC) patients. In this study,...
20.
Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy
Pang L, Gan J, Huang Y, Liao J, Zhuang W, Ali W, et al.
BMC Cancer
. 2023 Jan;
23(1):72.
PMID: 36670414
Background & Objective: "Anti-angiogenetic drugs plus chemotherapy" (anti-angio-chemo) and "immune checkpoint inhibitors plus chemotherapy" (ICI-chemo) are superior to traditional chemotherapy in the first-line treatment of patients with advanced non-small-cell lung...